Advertisement
Mr. Zylstra joins Mylan from the Pittsburgh Technology Council and thePittsburgh Biomedical Development Corporation where he served as President andCEO. He joined the Pittsburgh Technology Council et al after serving asDirector, Business Development, for Simula Technologies Inc. Prior to joiningSimula, Mr. Zylstra served as General Manager, General PneumaticsCorporation's Western Research Center, and, prior to that, he served asTechnical Manager for Bendix Guidance Systems Division. Mr. Zylstra joinsMylan with nearly 30 years of public relations, senior management, businessdevelopment, marketing, government relations and engineering experience,including the past seven years as a chief spokesman for the technology andmanufacturing industries in southwestern Pennsylvania.
Advertisement
Mylan Vice Chairman and CEO Robert J. Coury said: "In Steve, Mylan isadding yet another highly-seasoned, top-notch leader to further strengthen oursenior management team. His rich and diverse background steeped in technologyand manufacturing, makes him especially well suited to articulate the dynamicfuture and intrinsic complexities of both Mylan and of the generic andspecialty pharmaceuticals industries."
Mr. Zylstra said: "I am elated to be joining Mylan at thistransformational period in the Company's already prosperous history. I lookforward to working with the members of an extraordinary global management teamand supporting them and their operations with a world-class communicationsprogram as Mylan becomes the leading quality generic and specialtypharmaceutical company in the world."
Mr. Zylstra earned a bachelor's of science degree from Western MichiganUniversity.
Mylan Inc. is one of the world's leading quality generic and specialtypharmaceutical companies. The Company offers one of the industry's broadestand highest quality product portfolios, a robust product pipeline and a globalcommercial footprint through operations in more than 90 countries. Through itscontrolling interest in Matrix Laboratories Limited, Mylan has direct accessto one of the largest active pharmaceutical ingredient (API) manufacturers inthe world. Dey L.P., Mylan's fully integrated specialty business, provides theCompany with innovative and diversified opportunities in the respiratory andallergy therapeutic areas. For more information about Mylan, please visithttp://www.mylan.com.
SOURCE Mylan Inc.
